Loading...
 
Toggle Health Problems and D

Poor protein binding gene associated with poor Vitamin D response – RCT Nov 2019

Genetic Variation of the Vitamin D Binding Protein Affects Vitamin D Status and Response to Supplementation in Infants

J Clin Endocrinol Metab . 2019 Nov 1;104(11):5483-5498. doi: 10.1210/jc.2019-00630.
Maria Enlund-Cerullo 1 2 3, Laura Koljonen 2 3, Elisa Holmlund-Suila 1 3, Helena Hauta-Alus 1 3, Jenni Rosendahl 1 3, Saara Valkama 1 3, Otto Helve 1, Timo Hytinantti 1, Heli Viljakainen 2 4, Sture Andersson 1, Outi Mäkitie 1 2 3 5, Minna Pekkinen 1 2 3
Image

VitaminDWiki

Infants were given 1200 IU daily for 2 years
Note: 1200 IU is a lot for a newborn, but not much for a 2 year old

Vitamin D Binding Protein category listing has 178 items and the following introduction

Vitamin D Binding Protein (GC) gene can decrease the bio-available Vitamin D that can get to cells,

  • GC is not the only such gene - there are 3 others, all invisible to standard Vitamin D tests
  • The bio-available calculation does not notice the effect of GC, CYP27B1, CYP24A1, and VDR
  • The actual D getting to the cells is a function of measured D and all 4 genes
  • There is >2X increase in 8+ health problems if have poor VDBP (GC)
  • It appears that VDBP only blocks oral vitamin D,

Vitamin D Binding Protein has a list of health problems

Increased
Risk
Health Problem
11 XPreeclampsia
6.5XT1D in SA Blacks
6 XFood Allergy
5 XPTSD
4 X, 5XKidney Cancer
4 XPoor Response to Oral Vitamin D
3 XEar infection
2.8 X MS
2.5 XSevere Autism
2 X Colorectal Cancer
2 XProstate Cancer -in those with dark skins
1.3 XInfertility

Genetics category listing contains the following

343 articles in the Genetics category

see also

Vitamin D blood test misses a lot
in Visio for 2023

  • Vitamin D from coming from tissues (vs blood) was speculated to be 50% in 2014, and by 2017 was speculated to be 90%
  • Note: Good blood test results (> 40 ng) does not mean that a good amount of Vitamin D actually gets to cells
  • A Vitamin D test in cells rather than blood was feasible (2017 personal communication)   Commercially available 2019
    • However, test results would vary in each tissue due to multiple genes
  • Good clues that Vitamin D is being restricted from getting to the cells
    1) A vitamin D-related health problem runs in the family
        especially if it is one of 51+ diseases related to Vitamin D Receptor
    2) Slightly increasing Vitamin D shows benefits (even if conventional Vitamin D test shows an increase)
    3) DNA and VDR tests - 100 to 200 dollars $100 to $250
    4) PTH bottoms out ( shows that parathyroid cells are getting Vitamin d)
       Genes are good, have enough Magnesium, etc.
    5) Back Pain
       probably want at least 2 clues before taking adding vitamin D, Omega-3, Magnesium, Resveratrol, etc
      • The founder of VitaminDWiki took action with clues #3&5

 Download the PDF from VitaminDWiki

Context: Single nucleotide polymorphisms (SNPs) of the vitamin D binding protein encoding the GC (group component) gene affect 25-hydroxyvitamin D (25OHD) concentrations, but their influence on vitamin D status and response to vitamin D supplementation in infants is unknown.

Objective: To study GC genotype-related differences in 25OHD concentrations and the response to supplementation during a vitamin D intervention study in infants.

Design: In this randomized controlled trial, healthy term infants received vitamin D3 (10 or 30 μg/d) from 2 weeks to 24 months of age. GC SNPs rs2282679, rs4588, rs7041, and rs1155563 were genotyped. rs4588/7041 diplotype and haplotypes of rs2282679, rs4588, and rs7041 (Haplo3SNP) and of all four SNPs (Haplo4SNP) were determined.

Main outcome measures: 25OHD measured in cord blood at birth and at 12 and 24 months during intervention.

Results: A total of 913 infants were included. Minor allele homozygosity of all studied GC SNPs, their combined haplotypes, and rs4588/rs7041 diplotype 2/2 were associated with lower 25OHD concentrations at all time points in one or both intervention groups [analysis of covariance (ANCOVA) P < 0.043], with the exception of rs7041, which did not affect 25OHD at birth. In the high-dose supplementation group receiving 30 μg/d vitamin D3, but not in those receiving 10 µg/d, genotype of rs2282679, rs4588, and rs7041; diplotype; and Haplo3SNP significantly affected intervention response (repeated measurement ANCOVA Pinteraction < 0.019). Minor allele homozygotes had lower 25OHD concentrations and smaller increases in 25OHD throughout the intervention.

Conclusions: In infants, vitamin D binding protein genotype affects 25OHD concentration and efficiency of high-dose vitamin D3 supplementation.

Trial registration: ClinicalTrials.gov NCT01723852.


Created by admin. Last Modification: Tuesday March 2, 2021 11:57:36 GMT-0000 by admin. (Version 5)

Attached files

ID Name Comment Uploaded Size Downloads
15153 Response to 1200 IU.jpg admin 02 Mar, 2021 96.08 Kb 335
15152 Genetic Variation in VDBP and response.pdf admin 02 Mar, 2021 734.28 Kb 367